SHAREHOLDER ALERT: WeissLaw LLP Reminds STML, PTLA, and QES Shareholders About Its Ongoing Investigations

Editorial & Advertiser Disclosure Global Banking And Finance Review is an independent publisher which offers News, information, Analysis, Opinion, Press Releases, Reviews, Research reports covering various economies, industries, products, services and companies. The content available on globalbankingandfinance.com is sourced by a mixture of different methods which is not limited to content produced and supplied by various staff writers, journalists, freelancers, individuals, organizations, companies, PR agencies Sponsored Posts etc. The information available on this website is purely for educational and informational purposes only. We cannot guarantee the accuracy or applicability of any of the information provided at globalbankingandfinance.com with respect to your individual or personal circumstances. Please seek professional advice from a qualified professional before making any financial decisions. Globalbankingandfinance.com also links to various third party websites and we cannot guarantee the accuracy or applicability of the information provided by third party websites. Links from various articles on our site to third party websites are a mixture of non-sponsored links and sponsored links. Only a very small fraction of the links which point to external websites are affiliate links. Some of the links which you may click on our website may link to various products and services from our partners who may compensate us if you buy a service or product or fill a form or install an app. This will not incur additional cost to you. A very few articles on our website are sponsored posts or paid advertorials. These are marked as sponsored posts at the bottom of each post. For avoidance of any doubts and to make it easier for you to differentiate sponsored or non-sponsored articles or links, you may consider all articles on our site or all links to external websites as sponsored . Please note that some of the services or products which we talk about carry a high level of risk and may not be suitable for everyone. These may be complex services or products and we request the readers to consider this purely from an educational standpoint. The information provided on this website is general in nature. Global Banking & Finance Review expressly disclaims any liability without any limitation which may arise directly or indirectly from the use of such information.

NEW YORK, May 21, 2020 —

If you own shares in any of the companies listed above and would like to discuss our investigations or have any questions concerning this notice or your rights or interests, please contact:

Joshua Rubin, Esq. WeissLaw LLP 1500 Broadway, 16th Floor New York, NY  10036 (212) 682-3025 (888) 593-4771 [email protected]

Stemline Therapeutics, Inc. (NASDAQ: STML)

WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of Stemline Therapeutics, Inc. (NASDAQ: STML) in connection with the proposed acquisition of the company by A. Menarini-Industrie Farmaceutiche Riunite – S.r.l., a privately-held pharmaceutical company based in Italy.  Under the terms of the acquisition agreement, STML shareholders will receive $11.50 in cash and a contingent value right purportedly valued at $1.00 for each STML share that they own.  If you own STML shares and wish to discuss this investigation or your rights, please call us at one of the numbers listed above or visit our website: https://weisslawllp.com/stemline-therapeutics-inc/  

Portola Pharmaceuticals, Inc. (NASDAQ: PTLA)

WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of Portola Pharmaceuticals, Inc. (NASDAQ: PTLA) in connection with the proposed acquisition of the company by Alexion Pharmaceuticals, Inc. (“ALXN”).  Under the terms of the acquisition agreement, PTLA shareholders will receive $18.00 for each share of PTLA that they own.  If you own PTLA shares and wish to discuss this investigation or your rights, please call us at one of the numbers listed above or visit our website: https://weisslawllp.com/portola-pharmaceuticals-inc-ii/

Quintana Energy Services, Inc. (NYSE: QES)

WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of Quintana Energy Services, Inc. (NYSE: QES) in connection with the proposed acquisition of the company by KLX Energy Services Holdings, Inc. (“KLXE”).  Under the terms of the acquisition agreement, QES shareholders will receive 0.4844 shares of KLXE common stock for each QES share that they own, representing implied per-share merger consideration of approximately $0.75 based upon KLXE’s May 20, 2020 closing price of $1.54.  If you own QES shares and wish to discuss this investigation or your rights, please call us at one of the numbers listed above or visit our website: https://weisslawllp.com/quintana-energy-services-inc/

Primary Logo